Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cidara Therapeutics (CDTX) Consolidated Net Income: 2016-2024

Historic Consolidated Net Income for Cidara Therapeutics (CDTX) over the last 9 years, with Dec 2024 value amounting to $464,000.

  • Cidara Therapeutics' Consolidated Net Income fell 18396.22% to -$83.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$132.4 million, marking a year-over-year decrease of 2564.97%. This contributed to the annual value of $464,000 for FY2024, which is 78.41% down from last year.
  • Latest data reveals that Cidara Therapeutics reported Consolidated Net Income of $464,000 as of FY2024, which was down 78.41% from $2.1 million recorded in FY2023.
  • In the past 5 years, Cidara Therapeutics' Consolidated Net Income ranged from a high of $2.1 million in FY2023 and a low of -$72.1 million during FY2020.
  • For the 3-year period, Cidara Therapeutics' Consolidated Net Income averaged around -$10.3 million, with its median value being $464,000 (2024).
  • Per our database at Business Quant, Cidara Therapeutics' Consolidated Net Income surged by 106.40% in 2023 and then tumbled by 78.41% in 2024.
  • Yearly analysis of 5 years shows Cidara Therapeutics' Consolidated Net Income stood at -$72.1 million in 2020, then skyrocketed by 41.11% to -$42.5 million in 2021, then climbed by 20.92% to -$33.6 million in 2022, then spiked by 106.40% to $2.1 million in 2023, then crashed by 78.41% to $464,000 in 2024.